573 related articles for article (PubMed ID: 9527501)
21. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
[TBL] [Abstract][Full Text] [Related]
22. Orphanin FQ antagonizes the inhibition of Ca(2+) currents induced by mu-opioid receptors.
Zhang M; Wang X; Zhang D; Xu G; Dong H; Yu Y; Han J
J Mol Neurosci; 2005; 25(1):21-7. PubMed ID: 15781963
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of orphanin FQ/nociceptin and its fragments.
Rossi GC; Leventhal L; Bolan E; Pasternak GW
J Pharmacol Exp Ther; 1997 Aug; 282(2):858-65. PubMed ID: 9262352
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin/orphanin FQ dilates pial arteries by K(ATP) and K(ca) channel activation.
Armstead WM
Brain Res; 1999 Jul; 835(2):315-23. PubMed ID: 10415388
[TBL] [Abstract][Full Text] [Related]
25. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
[TBL] [Abstract][Full Text] [Related]
26. [Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?].
Kotlińska J; Rafalski P
Postepy Hig Med Dosw (Online); 2004 Apr; 58():209-15. PubMed ID: 15114256
[TBL] [Abstract][Full Text] [Related]
27. Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin.
Civelli O; Nothacker HP; Reinscheid R
Crit Rev Neurobiol; 1998; 12(3):163-76. PubMed ID: 9847053
[TBL] [Abstract][Full Text] [Related]
28. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
Thakker DR; Standifer KM
Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
[TBL] [Abstract][Full Text] [Related]
29. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
[TBL] [Abstract][Full Text] [Related]
30. Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord.
Pettersson LM; Sundler F; Danielsen N
Brain Res; 2002 Aug; 945(2):266-75. PubMed ID: 12126889
[TBL] [Abstract][Full Text] [Related]
31. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
32. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.
Darland T; Heinricher MM; Grandy DK
Trends Neurosci; 1998 May; 21(5):215-21. PubMed ID: 9610886
[TBL] [Abstract][Full Text] [Related]
33. Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.
Ko MC; Naughton NN; Traynor JR; Song MS; Woods JH; Rice KC; McKnight AT
Br J Pharmacol; 2002 Feb; 135(4):943-50. PubMed ID: 11861322
[TBL] [Abstract][Full Text] [Related]
34. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding.
Neal CR; Mansour A; Reinscheid R; Nothacker HP; Civelli O; Akil H; Watson SJ
J Comp Neurol; 1999 Oct; 412(4):563-605. PubMed ID: 10464356
[TBL] [Abstract][Full Text] [Related]
35. Functional studies using antibodies against orphanin FQ/nociceptin.
Tian JH; Han JS
Peptides; 2000 Jul; 21(7):1047-50. PubMed ID: 10998539
[TBL] [Abstract][Full Text] [Related]
36. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.
Judd AK; Kaushanskaya A; Tuttle DJ; Sanchez A; Khroyan T; Polgar W; Toll L
J Pept Res; 2003 Nov; 62(5):191-8. PubMed ID: 14531842
[TBL] [Abstract][Full Text] [Related]
37. Orphanin FQ/nociceptin analgesia in the rat.
Rossi GC; Perlmutter M; Leventhal L; Talatti A; Pasternak GW
Brain Res; 1998 May; 792(2):327-30. PubMed ID: 9593974
[TBL] [Abstract][Full Text] [Related]
38. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.
Fu X; Zhu ZH; Wang YQ; Wu GC
Neuroscience; 2007 Jan; 144(1):275-85. PubMed ID: 17069983
[TBL] [Abstract][Full Text] [Related]
39. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat.
Tian JH; Xu W; Fang Y; Mogil JS; Grisel JE; Grandy DK; Han JS
Br J Pharmacol; 1997 Feb; 120(4):676-80. PubMed ID: 9051307
[TBL] [Abstract][Full Text] [Related]
40. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
Chiou LC
Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
